Teleflex (TFX)

• Market cap: $8.27B
• 1 day: 1.93%
• 5 days: -0.69%
• 1 month: -4.95%
• 3 months: -26.53%
• 6 months: -11.84%
• Year to date: -28.86%
• 1 year: -28.05%
• 5 years: -52.21%
• 10 years: 51.82%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Employees: 14,500

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

99% more call options, than puts

Call options by funds: $5.07M | Put options by funds: $2.55M

50% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 3 (+1) [Q3]

33% more repeat investments, than reductions

Existing positions increased: 204 | Existing positions reduced: 153

7% more capital invested

Capital invested by funds: $10.3B [Q2] → $11B (+$763M) [Q3]

5% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 62

1% more funds holding

Funds holding: 515 [Q2] → 518 (+3) [Q3]

8.92% less ownership

Funds ownership: 103.5% [Q2] → 94.58% (-8.92%) [Q3]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $200 12% upside
• Avg. target: $232 30% upside
• High target: $250 40% upside

3 analyst ratings

• positive: 1 33%
• neutral: 2 67%
• negative: 0 0%

Truist Securities Richard Newitter 79% 1-year accuracy 33 / 42 met price target	12% upside $200	Hold Maintained	18 Dec 2024
Mizuho Anthony Petrone 39% 1-year accuracy 15 / 38 met price target	40% upside $250	Neutral Maintained	1 Nov 2024
RBC Capital Shagun Singh 51% 1-year accuracy 40 / 78 met price target	38% upside $245	Outperform Maintained	1 Nov 2024